# 2025-04252: Behind Closed Doors: Funding New Medical Product Ideas

2025-04252, National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, is a Federal Register notice from Health and Human Services Department, National Institutes of Health published 2025-03-17, effective 2025-04-14 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-04252
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-04252
- Title: National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
- Type: Notice
- Agencies: Health and Human Services Department; National Institutes of Health
- Citation: 90 FR 12329
- Published: 2025-03-17
- Effective: 2025-04-14
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Behind Closed Doors: Funding New Medical Product Ideas

## Summary

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 14, 2025, to review secret grant applications for new product development. This meeting affects researchers seeking funding and keeps sensitive info private. No public access means the focus is on protecting ideas and personal details while deciding who gets money.

## Effects PRIA read

- Closed NIH Review Protects Applicants' Secrets: benefit, low. The National Institute of Allergy and Infectious Diseases will hold a closed meeting on April 14, 2025 (10:00 a.m. to 1:30 p.m.) to review and evaluate grant applications for the R34 Planning for Product Development Strategy. The meeting is closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)…

## Related documents

- [2026-20771](https://policyrisk.com/federal-register/2026-20771): Center for Scientific Review; Notice of Closed Meetings, 2026-10-09
- [2026-20705](https://policyrisk.com/federal-register/2026-20705): Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With…, 2026-10-09
- [2026-20424](https://policyrisk.com/federal-register/2026-20424): National Cancer Institute; Notice of Meeting, 2026-10-06
- [2026-20365](https://policyrisk.com/federal-register/2026-20365): Center For Scientific Review; Notice of Closed Meetings, 2026-10-05
- [2026-20151](https://policyrisk.com/federal-register/2026-20151): Notice of NIH Tribal Consultations and Listening Session, 2026-10-01
- [2026-19719](https://policyrisk.com/federal-register/2026-19719): Center for Scientific Review; Amended Notice of Meeting, 2026-09-28

## Sources
- [2025-04252 on federalregister.gov](https://www.federalregister.gov/documents/2025/03/17/2025-04252/national-institute-of-allergy-and-infectious-diseases-notice-of-closed-meeting)
- [2025-04252 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-03-17/pdf/2025-04252.pdf)

## Related
- [Previous: 2025-04251, National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting](https://policyrisk.com/federal-register/2025-04251)
- [Next: 2025-04253, National Institute on Drug Abuse; Notice of Closed Meetings](https://policyrisk.com/federal-register/2025-04253)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-04252 (as of 2026-06-08).
